We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.2B
| $9.6M | 0.16% |
39,312
-360
| -0.9% | -$78.1K |
2013 Q2
42 quarters
|
|
102
Tesla
TSLA
$1.45T
| $9.24M | 0.15% |
36,503
-105
| -0.3% | -$25K |
2014 Q1
39 quarters
|
|
103
iShares MBS ETF
MBB
$35.4B
| $8.76M | 0.14% |
92,986
+1,331
| +1% | +$119K |
2013 Q2
42 quarters
|
|
104
Colgate-Palmolive
CL
$74.4B
| $8.39M | 0.14% |
105,932
-2,748
| -3% | -$207K |
2013 Q2
42 quarters
|
|
105
iShares US Treasury Bond ETF
GOVT
$42.1B
| $8.35M | 0.14% |
361,894
+360,042
| +19,441% | +$8.01M |
2022 Q1
7 quarters
|
|
106
Travelers Companies
TRV
$80.4B
| $8.32M | 0.14% |
43,953
-920
| -2% | -$159K |
2013 Q2
42 quarters
|
|
107
Comcast
CMCSA
$77.7B
| $7.88M | 0.13% |
178,507
-14,152
| -7% | -$607K |
2013 Q2
42 quarters
|
|
108
NVIDIA
NVDA
$5.24T
| $7.81M | 0.13% |
157,620
+29,070
| +23% | +$1.35M |
2019 Q3
17 quarters
|
|
109
Intel
INTC
$486B
| $7.73M | 0.13% |
153,479
-1,363
| -0.9% | -$55.4K |
2013 Q2
42 quarters
|
|
110
Sysco
SYY
$40.1B
| $7.73M | 0.13% |
105,804
-1,239
| -1% | -$85.5K |
2013 Q2
42 quarters
|
|
|
111
Enbridge
ENB
$105B
| $7.7M | 0.13% |
213,164
-1,410,711
| -87% | -$47.6M |
2013 Q2
42 quarters
|
|
112
Berkshire Hathaway Class A
BRK.A
$1.14T
| $7.63M | 0.12% |
14
| – | – |
2013 Q2
42 quarters
|
|
113
Lockheed Martin
LMT
$127B
| $7.33M | 0.12% |
16,246
+130
| +0.8% | +$57.6K |
2013 Q2
42 quarters
|
|
114
WEC Energy
WEC
$34.9B
| $7.2M | 0.12% |
85,700
-325
| -0.4% | -$26.8K |
2013 Q2
42 quarters
|
|
115
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.3B
| $7.05M | 0.11% |
78,332
-2,354
| -3% | -$195K |
2013 Q2
42 quarters
|
|
116
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $7M | 0.11% |
170,730
-7,656
| -4% | -$304K |
2013 Q2
42 quarters
|
|
117
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$19B
| $6.99M | 0.11% |
134,135
+7,415
| +6% | +$367K |
2013 Q2
42 quarters
|
|
118
Pfizer
PFE
$168B
| $6.94M | 0.11% |
241,228
-9,182
| -4% | -$278K |
2013 Q2
42 quarters
|
|
119
Schwab International Equity ETF
SCHF
$67.1B
| $6.8M | 0.11% |
367,684
+4,552
| +1% | +$79K |
2013 Q2
42 quarters
|
|
120
Broadcom
AVGO
$1.6T
| $6.68M | 0.11% |
59,500
-1,780
| -3% | -$169K |
2022 Q1
7 quarters
|
|
121
Vanguard Extended Market ETF
VXF
$29.6B
| $6.67M | 0.11% |
40,089
+109
| +0.3% | +$16K |
2013 Q2
42 quarters
|
|
122
McKesson
MCK
$118B
| $6.54M | 0.11% |
14,274
-139
| -1% | -$63.2K |
2013 Q2
42 quarters
|
|
123
Visa
V
$756B
| $6.49M | 0.11% |
24,935
+334
| +1% | +$82.3K |
2013 Q2
42 quarters
|
|
124
iShares National Muni Bond ETF
MUB
$50.8B
| $6.48M | 0.11% |
59,749
-31,393
| -34% | -$3.28M |
2014 Q1
39 quarters
|
|
125
Vanguard Total Bond Market
BND
$163B
| $6.31M | 0.1% |
85,559
-17,967
| -17% | -$1.27M |
2013 Q2
42 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.